Signaling Pathways - NAT10 - KDM - Insulin and Insulin-like Receptors - M1 Receptors
清除全部
- B4930 TC-E 5002Target: KDMSummary: 选择性组蛋白去甲基化酶KDM2/7亚家族抑制剂
- B4887 RemodelinTarget: NAT10Summary: NAT10抑制剂
- B6606 Telenzepine dihydrochloride中文名: 替仑西平二盐酸盐,太兰泽平二盐酸盐Target: M1 ReceptorsSummary: 毒蕈碱M1受体拮抗剂
- B1598 Biperiden HCl1 Citation中文名: 盐酸比哌立登Target: M1 ReceptorsSummary: 抗胆碱能药物
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A8369 Atropine sulfate monohydrate中文名: 硫酸阿托品一水合物Target: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 ReceptorsSummary: MAChRs拮抗剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A3348 Daminozide中文名: 丁酰肼Target: KDM|PHFSummary: KDM2A抑制剂